Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

OctoPlus gets drug delivery evaluation contract expansion with pharma company

OctoPlus, a drug delivery company, has won an expansion of a drug delivery technology evaluation contract with an existing client, a pharma company.

The pharma company has decided to proceed with the evaluation of OctoPlus’ PolyActive technology for an additional product candidate in its pipeline.

Under the contract, OctoPlus will evaluate the feasibility of a controlled release formulation that combines the client’s product candidate with OctoPlus’ proprietary drug delivery technology.

OctoPlus said that if the evaluation is successful, the contract may progress to a full process development, manufacturing and licensing agreement.